Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program

Journal of Clinical Oncology

Volumn 21, Issue 24, 2003, Pages 4635-4641

  Morrow, Gary R ^a   Hickok, Jane T ^a   Roscoe, Joseph A ^a   Raubertas, Richard F ^a   Andrews, Paul L R ^a   Flynn, Patrick J ^a   Hynes, Harry E ^a   Banerjee, Tarit K ^a   Kirshner, Jeffrey J ^a   King, David K ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CANCER CENTER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; ADULT; AGED; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; FEMALE; MALE; MIDDLE AGED; NEOPLASM; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DEPRESSION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 1542543332     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.04.070     Document Type: Article

References (34)

1. Varricchio CG: Selecting a tool for measuring fatigue. Oncol Nurs Forum 12:122-127, 1985
2. Broeckel JA, Jacobsen PB, Balducci L, et al: Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 62:141-150, 2000
3. Stone P, Richards M, Hardy J: Fatigue in patients with cancer. Eur J Cancer 34:1670-1676, 1998
4. Stone P, Richardson A, Ream E, et al: Cancer-related fatigue: Inevitable, unimportant, and unbeatable? Results of a multi-centre patient survey: Cancer Fatigue Forum. Ann Oncol 11:971-975, 2000
5. Piper BF: Subjective fatigue in women receiving six cycles of adjuvant chemotherapy for breast cancer [dissertation]. San Francisco, CA: University of California; 1992
6. Home J: Sleep deprivation, in Why We Sleep. New York, NY, Oxford University Press, 1989, pp 13-78
7. Miller RG, Giannini D, Milner-Brown HS, et al: Effects of fatiguing exercise on high-energy phosphates, force and EMG: Evidence for three phases of recovery. Muscle Nerve 10:810-821, 1987
8. Blesch KS, Pake JA, Wickham R, et al: Correlates of fatigue in people with breast or lung cancer. Oncol Nurs Forum 18:81-87, 1991
9. Jacobsen PB, Hann DM, Azzarello LM, et al: Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course and correlates. J Pain Symptom Manage 18:233-242, 1999
10. Fobair P, Hoppe RT, Bloom J, et al: Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 4:805-814, 1986
11. Devlen J, Maguire P, Phillips P, et al: Psychosocial problems associated with diagnosis and treatment of lymphomas. I: Retrospective study. BMJ 295:953-957, 1987
12. Kubricht DW: Therapeutic self-care demands expressed by outpatients receiving external radiation therapy. Cancer Nurs 7:43-52, 1984
13. Mitchell GW, Glicksman AS: Cancer patients: Knowledge and attitudes. Cancer 40:61-66, 1977
14. Jamar SC: Fatigue in women receiving chemotherapy for ovarian cancer, in Funk S, Tornquist E, Champagne M, et al (eds): Key Aspects of Comfort: Management of Pain, Fatigue and Nausea. New York, NY, Springer, 1989, pp 224-228
15. Piper BF, Lindsey AM, Dodd MJ, et al: The development of an instrument to measure the subjective dimension of fatigue, in Funk SG, Tornquist EM, Champagne MT, et al (eds): Key Aspects of Comfort: Management of Pain, Fatigue, and Nausea. New York, NY, Springer, 1989, pp 199-208
16. Wessely S, Hotopf M, Sharpe MC: Chronic Fatigue and Its Syndromes. New York, NY, Oxford University Press, 1999, pp 226-227
17. Andrews PLR, Morrow GR: Approaches to understanding the mechanisms involved in fatigue associated with cancer and its treatments: A speculative review, in Marty M, Pecorelli S (eds): Fatigue and Cancer. London, UK, Elsevier Science, 2001, pp 79-83
18. Murphy DL, Campelli I, Costa JL: Current status of the indoleamine hypothesis of the affective disorders, in Lipton MA, DiMasco A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, NY, Raven Press, 1978, pp 1235-1247
19. Tollefson DL, Rosenbaum JF: Selective serotonin reuptake inhibitors, in Schatzberg AF, Nemeroff CB (eds): Textbook of Psychopharmacology (ed 2). Washington, DC, American Psychiatric Press, 1998, pp 219-237
20. Bearn J, Wessely S: Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest 24:79-90, 1994
21. Dunbar GC, Claghorn JL, Kiev A, et al: A comparison of paroxetine and placebo in depressed outpatients. Acta Psychiatr Scand 87:302-305, 1993
22. Yoshitake H: Three characteristic patterns of subjective fatigue symptoms. Ergonomics 21:231-233, 1978
23. Tack B. Dimensions and correlates of fatigue in older adults with rheumatoid arthritis [dissertation]. San Francisco, CA: University of California; 1991
24. McNair DM, Lorr M, Droppelman, LF: Manual for the Profile of Mood States. San Diego, CA, Educational and Industrial Testing Service, 1971
25. Pugh LC. Psychophysiological correlates of fatigue during childbirth [dissertation].College Park, MD: University of Maryland; 1990
26. Belza BL, Henke CJ, Yelin EH, et al: Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42:93-99, 1993
27. Belza BL: Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 22:639-643, 1995
28. Radloff LS: The CES-D scale: A self-report depressive scale for research in the general population. Appl Psychol Meas 1:385-401, 1977
29. Turk DC, Okifuji A: Detecting depression in chronic pain patients: Adequacy of self-reports. Behav Res Ther 32:9-16, 1994
30. Hann D, Winter K, Jacobsen P: Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437-443, 1999
31. Caley CF, Weber SS: Paroxetine: A selective serotonin reuptake inhibiting antidepressant. Ann Pharmacother 27:1212-1222, 1993
32. Breitbart W, Rosenfeld B, Kaim M, et al: A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161:411-420, 2001
33. Morrow GR, Andrews PL, Hickok JT, et al: Fatigue associated with cancer and its treatment. Support Care Cancer 10:389-398, 2002
34. Prins JB, Bleijenberg G, Bazelmans E, et al: Cognitive behavior therapy for chronic fatigue syndrome: A multicentre randomized controlled trial. Lancet 357:841-847, 2001